Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 17265392)

Published in Infect Control Hosp Epidemiol on January 26, 2007

Authors

Steven J Lawrence1, Laura A Puzniak, Brooke N Shadel, Kathleen N Gillespie, Marin H Kollef, Linda M Mundy

Author Affiliations

1: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. slawrenc@im.wustl.edu

Articles citing this

The economic burden of Clostridium difficile. Clin Microbiol Infect (2011) 1.74

Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis (2013) 1.64

Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease. J Clin Microbiol (2010) 1.38

Outcome of ICU patients with Clostridium difficile infection. Crit Care (2012) 1.38

Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol (2009) 1.33

Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol (2011) 1.16

Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan. PLoS One (2012) 1.02

Clostridium difficile in the ICU: the struggle continues. Chest (2011) 1.01

Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am (2009) 0.93

ICU-Onset Clostridium difficile infection in a university hospital in China: a prospective cohort study. PLoS One (2014) 0.91

An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study. PLoS One (2016) 0.88

Recognition and prevention of hospital-associated enteric infections in the intensive care unit. Crit Care Med (2010) 0.88

Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol (2016) 0.86

Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care (2015) 0.85

Diarrhoea associated with antibiotic use. BMJ (2007) 0.84

Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure. PLoS One (2013) 0.82

Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis. Open Forum Infect Dis (2015) 0.81

Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect (2009) 0.81

Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008. Public Health Rep (2012) 0.81

Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care. World J Gastroenterol (2013) 0.81

Measurement and Impact of Staphylococcus aureus Colonization Pressure in Households. J Pediatric Infect Dis Soc (2013) 0.80

Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control (2012) 0.80

Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit. Am J Gastroenterol (2016) 0.79

Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed. JAMA Intern Med (2016) 0.79

Clostridium difficile Associated Disease in a Neurointensive Care Unit. Front Neurol (2013) 0.78

Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. Am J Infect Control (2016) 0.77

Diarrhoea in the critically ill is common, associated with poor outcome, and rarely due to Clostridium difficile. Sci Rep (2016) 0.76

Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study. Eur J Clin Microbiol Infect Dis (2016) 0.76

A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus (2016) 0.75

Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis (2016) 0.75

Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study. PLoS One (2016) 0.75

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity. PLoS One (2016) 0.75

Morbidity and mortality in severely burned children with Clostridium difficile-associated diarrhea. Surgery (2016) 0.75

Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing. Braz J Microbiol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest (2006) 4.51

Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (2006) 4.10

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98

Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs (2007) 3.63

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother (2005) 3.49

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20

Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 3.13

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA (2012) 3.13

The importance of fluid management in acute lung injury secondary to septic shock. Chest (2009) 2.92

Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy. Crit Care Med (2015) 2.87

Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis. Crit Care Med (2015) 2.86

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med (2005) 2.70

Computed tomography characteristics of Burkholderia pseudomallei liver abscess. Clin Infect Dis (2006) 2.64

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59

Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest (2008) 2.57

Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med (2009) 2.57

Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med (2006) 2.51

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49

Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med (2011) 2.35

Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest (2013) 2.32

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest (2004) 2.26

Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit Care Med (2004) 2.20

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med (2011) 2.16

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med (2010) 2.15

Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr (2002) 2.15

Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol (2004) 2.13

Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09

Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis (2002) 2.09

Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission. Chest (2015) 2.09

Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med (2008) 2.06

A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther (2007) 2.05

Attitudes of respiratory therapists and nurses about measures to prevent ventilator-associated pneumonia: a multicenter, cross-sectional survey study. Respir Care (2007) 2.03

Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med (2005) 1.92

Prevention Research Centers: contributions to updating the public health workforce through training. Prev Chronic Dis (2005) 1.91

Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med (2007) 1.88

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med (2006) 1.86

Improving the public health workforce: evaluation of a training course to enhance evidence-based decision making. J Public Health Manag Pract (2008) 1.82

A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med (2012) 1.82

Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest (2008) 1.81

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med (2006) 1.80

To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis (2002) 1.76

Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med (2002) 1.72

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Crit Care Med (2008) 1.72

Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med (2009) 1.71

Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest (2002) 1.63

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care (2012) 1.62

Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. Crit Care Med (2003) 1.61

Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert. Crit Care Med (2014) 1.60

Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60

Atypical avian influenza (H5N1). Emerg Infect Dis (2004) 1.60

A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest (2015) 1.59

Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58

Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med (2006) 1.57

Use of a handheld computer by respiratory care practitioners to improve the efficiency of weaning patients from mechanical ventilation. Crit Care Med (2002) 1.56

The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chest (2007) 1.53

Patient safety event reporting in critical care: a study of three intensive care units. Crit Care Med (2007) 1.51

A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults. Respir Care (2011) 1.51

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin. Crit Care Med (2004) 1.49

Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest (2008) 1.47

Non-invasive stroke volume measurement and passive leg raising predict volume responsiveness in medical ICU patients: an observational cohort study. Crit Care (2009) 1.47

Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest (2009) 1.47

Physicians' estimates of cardiac index and intravascular volume based on clinical assessment versus transesophageal Doppler measurements obtained by critical care nurses. Am J Crit Care (2003) 1.46

Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest (2004) 1.45

Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care (2011) 1.45

Prevention of hospital infection. Microbes Infect (2005) 1.45

Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation. Crit Care Med (2010) 1.42

Ambulatory care-sensitive conditions: clinical outcomes and impact on intensive care unit resource use. South Med J (2003) 1.42

Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol (2008) 1.42

Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clin Infect Dis (2005) 1.40

Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. Surg Infect (Larchmt) (2007) 1.39

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care (2006) 1.37

Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter? Infect Control Hosp Epidemiol (2010) 1.34

Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care (2010) 1.33

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther (2003) 1.33

Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting. Chest (2007) 1.30

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother (2010) 1.27

Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis (2004) 1.26

Diabetes burden and access to preventive care in the rural United States. J Rural Health (2010) 1.26

Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25

Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med (2002) 1.25

The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest (2004) 1.24

Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J (2008) 1.20

Transfusion practice and blood stream infections in critically ill patients. Chest (2005) 1.19

Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. Chest (2002) 1.18

The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis (2007) 1.18

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care (2012) 1.18

An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest (2004) 1.16

Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med (2004) 1.15

Fluid balance and cardiac function in septic shock as predictors of hospital mortality. Crit Care (2013) 1.14

Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med (2005) 1.13

Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis (2004) 1.13

Reporting of medical errors: an intensive care unit experience. Crit Care Med (2004) 1.13

Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis (2010) 1.12